Hosted on MSN35m
MolecuLight secures investment from Hayfin for global expansion
MolecuLight has secured a $27.5m investment from Hayfin Capital Management, aimed at propelling the company's growth across ...
Denali Therapeutics Announces Topline Results for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
Primary endpoint of overall function (ALSFRS-R) and survival, and key secondary endpoints of muscle strength and respiratory function, were not ...